Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

OGN · Organon & Co.

$13.74 -0.07% Oct 26 close
No confirmed setup in the latest scan

That is a valid result; the scanner does not force a pattern.

Ask about OGN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$OGN

Organon & Co.

Organon & Co. is a mid-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $4B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 1
$13.74 latest close
Market Structure
Trend structure: range
Latest event: bos (bullish)
Inside 13.28–13.83 · 28 touches · strong
Momentum Turn Watch
Bollinger Squeeze Bollinger band width (0.8%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Earnings

Normal technical setup

Next earnings Monday, November 9, 2026 Report time not confirmed by the source

Deterministic evidence

OGN-0.07%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. OGN was -0.07 points vs XLV. -0.78 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-0.07% From the open-0.07% Range position0% GapNo gap
QQQ confirmationDiverging (+1.11%) SMH confirmationDiverging (+2.74%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $13.74 -0.1% Oct 26 close
52W High $13.83 0.7% below high
Wks Since High 2w
Base Depth 0.8%
SMA 50 $13.73
Avg Vol 2,615,874
Rel Vol (Oct 26) 0.59× 1.22× on up days
More stats
52W Low $5.69
Tight Wks 13
Base B1
SMA 200 $11.41
Group Rank #13/66
ADR% 0.3%
ATR(14) $0.04 (0.3%)
Vol Pace (live) N/A
A/D Days 11A / 5D
A/D Rating A+
Earnings in 13d
Position in 52-week range 99thpercentile of the 52-week range
$5.69low
$13.83high
Pending acquisition — not a tradable setup. OGN is being acquired by Sun Pharmaceutical Industries (Sun Pharma USA) for $14.00 per share in cash (announced Apr 26, 2026, shareholder-approved Jul 23, 2026). Upside is capped at the deal price and the chart's tightness reflects merger arbitrage, not accumulation. Any pattern shown below is excluded from scan rankings for this reason.

OGN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for OGN.

Create Free Account

Technical Analysis Report Card

$OGN · $13.74 · as of 2026-10-26 · multi-factor read
68
/ 100
Buy

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$13.73 ↑
100-day$13.62 ↑
200-day$11.41 ↑
Bullish (50 > 200)

RSI (14)

Reading50.5 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.004

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width43% · 0.8%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.22 · Neutral
Rel volume0.59×
Pocket pivots · 10d0
5d vs 50d vol76%
Heavy vol up / down0 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $13.8052-week high
Price · $13.74now
S · $13.70swing level
S · $13.45swing level
S · $8.51swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$13.70
38.2% ◄ price here$13.62
50.0% ◄ price here$13.55
61.8%$13.49
78.6%$13.40

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for OGN — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about OGN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
174RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +3 A+
A: 5 D: 2 Net: +365 sessions

No patterns detected

This symbol didn't match any pattern in the latest scan.

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $13.74 vs SMA150 $12.65 / SMA200 $11.41
SMA 150 above SMA 200 SMA150 $12.65 vs SMA200 $11.41
SMA 200 trending up Slope +0.65 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $13.73
Price above SMA 50 $13.74 vs SMA50 $13.73
30%+ above 52-week low +141.5% from $5.69
Within 25% of 52-week high -0.7% from $13.83
RS score above 70 RS 50

Fundamentals

52W Range
99%
Mkt Cap SEC
3.6B
EPS QoQ
+13%
Rev YoY
-3%
ROE
30%
Gross Margin
53%
D/E
11.49
EPS TTM
$0.72
P/E TTM
19.1x
Float
263M
Insider
No Buy

Company

Company profile
Organon & Co.
OGN · NYSE · Health Technology · Pharmaceuticals: Major

Scan History

Sep 24: 86 (Three Weeks Tight)Sep 24: 94 (Flat Base)Sep 24: 95 (Flat Base)Sep 25: 86 (Three Weeks Tight)Sep 25: 87 (Three Weeks Tight)Sep 25: 87 (Three Weeks Tight)87
Sep 25
Three Weeks Tight ✓ Gate
87
Sep 25
Three Weeks Tight ✓ Gate
87 +0.1%
Sep 25
Three Weeks Tight ✓ Gate
86 +0.1%
Sep 24
Flat Base ✓ Gate
95 +0.1%
Sep 24
Flat Base ✓ Gate
94 +0.1%
Sep 24
Three Weeks Tight ✓ Gate
86 +0.1%

Latest News

Headlines for OGN
Loading headlines…

Get the full picture on OGN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial